IGF-1 LR3 ONE 5 mg

IGF-1 LR3 ONE is a 5 mg peptide formulation developed by OMEGA ONE Pharmaceuticals, with a focus on purity, consistency, and stability for specialized research applications.

Product Overview

IGF-1 LR3 is a modified analog of insulin-like growth factor 1 that has attracted substantial scientific interest due to its extended biological activity and interaction with IGF-related signaling pathways. IGF-1 LR3 ONE 5 mg expands the OMEGA ONE portfolio with a specialized formulation designed for advanced research into cellular growth, protein synthesis, metabolism, and tissue-development mechanisms.

Characteristics

• Active Compound: IGF-1 LR3 (Long R3 Insulin-Like Growth Factor 1)
• Strength: 5 mg
• Form: Lyophilized peptide/protein
• Peptide Structure: Modified analog of human IGF-1
• Research Focus: Investigated in experimental research involving IGF-1 receptor signaling, cellular growth and differentiation, protein synthesis, glucose metabolism, and tissue-development pathways.
• Quality: High-purity formulation designed for consistency and stability
• Brand: OMEGA ONE Pharmaceuticals
• Storage: Store according to product specifications; refrigeration is generally required after reconstitution
• Professional Use: Intended for specialized applications in accordance with applicable regulations

Presentation
1 vial of Lyophilized Powder
1 vial of Diluent – 3 mL